Lyme Disease Vaccines
Recombinant OspA vaccine (withdrawn)
This page catalogs 1 Lyme disease vaccine product. LYMErix was the only Lyme disease vaccine ever licensed for human use. It was voluntarily withdrawn from the market in 2002 due to low demand, not a regulatory safety action.
Last updated: April 2026.
Lyme Disease Vaccine Catalog
| Trade Name | Generic Designation | Manufacturer | Vaccine Type | Regulatory Status & Year | Key Notes |
|---|---|---|---|---|---|
| LYMErix | Lyme disease vaccine (OspA) | GSK (SmithKline Beecham) | Recombinant OspA | FDA Licensed, 1998; Withdrawn 2002 | Voluntarily withdrawn due to low demand |
Sources
Regulatory data sourced from FDA CBER Vaccines Licensed for Use in the United States (March 2026) and FDA historical archives. Catalog scope informed by Khan, Shaz, The Ultimate Vaccine Timeline.